Your browser doesn't support javascript.
loading
Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression.
Zhang, Lu; Fang, Yu; Cheng, Xuan; Lian, Ya-Jun; Xu, Hong-Liang; Zeng, Zhao-Shu; Zhu, Hong-Can.
Afiliação
  • Zhang L; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Fang Y; Department of Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Cheng X; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Lian YJ; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Xu HL; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zeng ZS; Department of Legal Medicine, The College of Basic Medical Sciences of Zhengzhou University, Zhengzhou, China.
  • Zhu HC; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Neurol ; 8: 531, 2017.
Article em En | MEDLINE | ID: mdl-29062301
BACKGROUND: To validate our speculation that curcumin may ameliorate Alzheimer's disease (AD) pathogenesis by regulating PI(3,5)P2 and transient receptor potential mucolipin-1 (TRPML1) expression levels. METHODS: We developed an animal model presenting AD by APP/PS1 transgenes. The mouse clonal hippocampal neuronal cell line HT-22 was treated with amyloid-ß1-42 (Aß1-42). Curcumin was administrated both in vivo and in vitro. MTS assay was used to detect cell viability, and the lysosomal [Ca2+] ion concentration was detected. The number of autophagosomes was detected by the transmission electron microscopic examination. Illumina RNA-seq was used to analyze the different expression patterns between Aß1-42-treated cells without and with curcumin treatment. The protein level was analyzed by the Western blotting analysis. PI(3,5)P2 or TRPML1 was knocked down in HT-22 cells or in APP/PS1 transgenic mice. Morris water maze and recognition task were performed to trace the cognitive ability. RESULTS: Curcumin increased cell viability, decreased the number of autophagosomes, and increased lysosomal Ca2+ levels in Aß1-42-treated HT-22 cells. Sequencing analysis identified TRPLML1 as the most significantly upregulated gene after curcumin treatment. Western blotting results also showed that TRPML1 was upregulated and mTOR/S6K signaling pathway was activated and markers of the autophagy-lysosomal system were downregulated after curcumin use in Aß1-42-treated HT-22 cells. Knockdown of PI (3,5)P2 or TRPML1 increased the protein levels of markers of the autophagy-lysosomal system after curcumin use in Aß1-42-treated HT-22 cells, inhibited mTOR/S6K signaling pathway, increased the protein levels of markers of the autophagy-lysosomal system after curcumin use in APP/PS1 mice. Besides, knockdown of PI(3,5)P2 or TRPML1 reversed the protective role of curcumin on memory and recognition impairments in mice with APP/PS1 transgenes. CONCLUSION: To some extent, it suggested that the effects of curcumin on AD pathogenesis were, at least partially, associated with PI(3,5)P2 and TRPML1 expression levels.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Neurol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Neurol Ano de publicação: 2017 Tipo de documento: Article